Mingzhao Xing

Molecular Biology · 2003–2014

A researcher in the Science corpus: 6 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 30 citations into it; #11,428 of 17,773 by trust here, #10,506 by citations
• Endocrinology, Diabetes and Metabolism — 21 citations into it; #311 of 623 by trust here, #314 by citations
• Oncology — 21 citations into it
• Cancer Research — 9 citations into it

Whom Mingzhao Xing trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Michael Mingzhao Xing
2. M. Karin
3. M. Nikiforova
4. Jean-Pierre Issa
5. P. Soares

Who trusts Mingzhao Xing overall

1. Y. Nikiforov
2. M. Nikiforova

Papers from Mingzhao Xing's perspective

Ordered by how strongly the researchers Mingzhao Xing trusts endorse each paper. Same corpus, a different order for every researcher.

1. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status (Nature)
2. BRAF mutation in thyroid cancer. (Endocrine-Related Cancer)
3. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. (Journal of Clinical Endocrinology and Metabolism)
4. Molecular pathogenesis and mechanisms of thyroid cancer (Nature Reviews. Cancer)
5. Thyroid carcinoma. (The Journal of the National Comprehensive Cancer Network)
6. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. (Endocrine reviews)
7. Highly recurrent TERT promoter mutations in human melanoma (Science)
8. TERT Promoter Mutations in Familial and Sporadic Melanoma (Science)
9. Mutations of the BRAF gene in human cancer (Nature)
10. Global cancer statistics (Ca)

Their papers

• BRAF mutation in papillary thyroid carcinoma. (2003) — 894 citations
• BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. (2007) — 1,003 citations
• BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. (2014) — 650 citations
• Molecular pathogenesis and mechanisms of thyroid cancer (2013) — 1,384 citations
• Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer (2013) — 903 citations
• BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. (2005) — 1,008 citations